Prediction of cancer outcome using DNA microarray technology: past, present and future

Bibliography

• Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70
   PubMed Web of Science ®Google Scholar
• Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996;14:1675-80
   PubMed Web of Science ®Google Scholar
• Veer V, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-6
   PubMed Web of Science ®Google Scholar
• Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-7
   PubMed Web of Science ®Google Scholar
• Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001;98:13790-5
   PubMed Web of Science ®Google Scholar
• Singh D, Febbo PG, Ross K, et al. Gene expression correlates of clinical prostate cancer behaviour. Cancer Cell 2002;1:203-9
   PubMed Web of Science ®Google Scholar
• Spentzos D, Levine DA, Ramoni MF, et al. Gene expression signature with independent prognostic significance in epithelial ovarian cancer. J Clin Oncol 2004;22:4700-10
   PubMed Web of Science ®Google Scholar
• Spentzos D, Levine DA, Kolia S, et al. Unique gene expression profile based on pathologic response in epithelial ovarian cancer. J Clin Oncol 2005;23:7911-8
   PubMed Web of Science ®Google Scholar
• van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009
   PubMed Web of Science ®Google Scholar
• Venter JC, Adams MD, Myers EW, et al. The Sequence of the Human Genome. Science 2001;291:1304-51
   PubMed Web of Science ®Google Scholar
• Shedden K, Taylor J, Enkemann S, et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 2008;14(8):822-7
   PubMed Web of Science ®Google Scholar
• Clarke R, Ressom H, Wang A, et al. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat Rev Cancer 2008;8:37-49
   PubMed Web of Science ®Google Scholar
• Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-21
   PubMed Web of Science ®Google Scholar
• Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002;99:6567-72
   PubMed Web of Science ®Google Scholar
• Pochet N, De Smet F, Suykens J, De Moor B. Systematic benchmarking of microarray data classification: assessing the role of non-linearity and dimensionality reduction. Bioinformatics 2004;20:3185-95
   PubMed Web of Science ®Google Scholar
• Alon U, Barkai N, Notterman DA, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 1999;96:6745-50
   PubMed Web of Science ®Google Scholar
• Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001;98:13790-5
   PubMed Web of Science ®Google Scholar
• Schwartz DR, Kardia SL, Shedden KA, et al. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 2002;62:4722-9
   PubMed Web of Science ®Google Scholar
• Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70
   PubMed Web of Science ®Google Scholar
• DeRisi J, Penland L, Brown PO, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996;14:457-60
   PubMed Web of Science ®Google Scholar
• Lipshutz RJ, Morris D, Chee M, et al. Using oligonucleotide probe arrays to access genetic diversity. BioTechniques 1995;19:442-7
   PubMed Web of Science ®Google Scholar
• Yang YH, Buckley MJ, Dudoit S, Speed TP. Comparison of Methods for Image Analysis on cDNA Microarray Data. J Comput Graphical Stat 2002;11(1):108-36
   Web of Science ®Google Scholar
• Irizarry R, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostat 2003;4:249-64
   PubMed Web of Science ®Google Scholar
• Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002;32(Suppl):496-501
   PubMed Web of Science ®Google Scholar
• Kerr G, Ruskin HJ, Crane M, Doolan P. Techniques for clustering gene expression data. Comput Biol Med 2008;38:283-93
   PubMed Web of Science ®Google Scholar
• Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007;356:11-20
   PubMed Web of Science ®Google Scholar
• Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 2001;98:15149-54
   PubMed Web of Science ®Google Scholar
• Berrar D, Bradbury I, Dubitzky W. Instance-based concept learning from multiclass DNA microarray data. BMC Bioinformatics 2006;7:73
   PubMedGoogle Scholar
• Prasad NB, Somervell H, Tufano RP, et al. Identification of genes differentially expressed in benign versus malignant thyroid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14:3327-37
   PubMed Web of Science ®Google Scholar
• Khan J, Wei JS, Ringnér M, et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001;7:673-9
   PubMed Web of Science ®Google Scholar
• Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002;99:6567-72
   PubMed Web of Science ®Google Scholar
• Mitchell T. Machine Learning. McGraw-Hill Science/Engineering/Math, 1997
   Google Scholar
• Slonim DK. From patterns to pathways: gene expression data analysis comes of age. Nat Genet 2002;32(Suppl):502-8
   PubMed Web of Science ®Google Scholar
• Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-7
   PubMed Web of Science ®Google Scholar
• Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52
   PubMed Web of Science ®Google Scholar
• Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003;100:8418-23
   PubMed Web of Science ®Google Scholar
• Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001;98:13790-5
   PubMed Web of Science ®Google Scholar
• Alon U, Barkai N, Notterman DA, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 1999;96:6745-50
   PubMed Web of Science ®Google Scholar
• Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002;99:6567-72
   PubMed Web of Science ®Google Scholar
• West M, Blanchette C, Dressman H, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 2001;98:11462-7
   PubMed Web of Science ®Google Scholar
• Beer D, Kardia S, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002;8:816-24
   PubMed Web of Science ®Google Scholar
• Buyse M, Loi S, Van't Veer L, et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 2006;98:1183-92
   PubMed Web of Science ®Google Scholar
• Ransohoff DF. Gene-expression signatures in breast cancer. N Engl J Med 2003;348:1715-7
   PubMedGoogle Scholar
• Kunkler IH. Gene-expression signatures in breast cancer. N Engl J Med 2003;348:1715-7
   PubMedGoogle Scholar
• Kopans DB. Gene-expression signatures in breast cancer. N Engl J Med 2003;348:1715-7
   PubMedGoogle Scholar
• Helmbold P, Haerting J, Kölbl H. Gene-expression signatures in breast cancer. N Engl J Med 2003;348:1715-7
   PubMedGoogle Scholar
• Wang Y, Klijn JG, Zhang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005;365:671-9
   PubMed Web of Science ®Google Scholar
• Ein-Dor L, Kela I, Domany E. Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 2005;21:171-8
   PubMed Web of Science ®Google Scholar
• Ein-Dor L, Zuk O, Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 2006;103:5923-8
   PubMed Web of Science ®Google Scholar
• Bueno-De-Mesquita JM, van Harten WH, Retel VP, et al. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER). Lancet Oncol 2007;8:1079-87
   PubMed Web of Science ®Google Scholar
• Cardoso F, Van't Veer L, Rutgers E, et al. Clinical application of the 70-gene profile: the MINDACT trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2008;26:729-35
   PubMed Web of Science ®Google Scholar
• Sotiriou C, Piccart M. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer 2007;7:545-53
   PubMed Web of Science ®Google Scholar
• Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817-26
   PubMed Web of Science ®Google Scholar
• Esteva FJ, Sahin AA, Cristofanilli M, et al. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy. Clin Cancer Res 2005;11:3315-9
   PubMed Web of Science ®Google Scholar
• Habel L, Shak S, Jacobs M, et al. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res 2006;8:R25
   PubMed Web of Science ®Google Scholar
• Sparano JA. TAILORx: trial assigning individualized options for treatment (Rx). Clin Breast Cancer 2006;7:347-50
   PubMed Web of Science ®Google Scholar
• Sparano JA, Paik S. Development of the 21-gene assay and its application in clinical practice and clinical trials. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2008;26:721-8
   PubMed Web of Science ®Google Scholar
• Dupuy A, Simon RM. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 2007;99:147-57
   PubMed Web of Science ®Google Scholar
• Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005;37(Suppl):S11-17
   PubMed Web of Science ®Google Scholar
• Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003;422:198-207
   PubMed Web of Science ®Google Scholar
• Dalton WS, Friend SH. Cancer biomarkers–an invitation to the table. Science 2006;312:1165-8
   PubMed Web of Science ®Google Scholar
• Koomen JM, Haura EB, Bepler G, et al. Proteomic contributions to personalized cancer care. Mol Cell Proteomics 2008;7(10):1780-94
   PubMed Web of Science ®Google Scholar
• MacBeath G. Protein microarrays and proteomics. Nat Genet 2002;32:526-32
   PubMed Web of Science ®Google Scholar
• Calin GA, Liu CG, Sevignani C, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004;101:11755-60
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148-59
   PubMed Web of Science ®Google Scholar
• Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005;37(Suppl):S11-17
   PubMed Web of Science ®Google Scholar
• Redon R, Ishikawa S, Fitch K, et al. Global variation in copy number in the human genome. Nature 2006;444:444-54
   PubMed Web of Science ®Google Scholar
• Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005;37(Suppl)
   Google Scholar
• Fridlyand J, Snijders AM, Ylstra B, et al. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 2006;6
   PubMedGoogle Scholar
• Snijders A, Schmidt B, Fridlyand J, et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 2005;24:4232-42
   PubMed Web of Science ®Google Scholar
• Garnis C, Lockwood W, Vucic E, et al. High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int J Cancer 2006;118:1556-64
   PubMed Web of Science ®Google Scholar
• Chin K, DeVries S, Fridlyand J, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006;10:529-41
   PubMed Web of Science ®Google Scholar
• Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003;422:198-207
   PubMed Web of Science ®Google Scholar
• Cox J, Mann M. Is proteomics the new genomics? Cell 2007;130:395-8
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7
   PubMed Web of Science ®Google Scholar
• Rockhill B. Proteomic patterns in serum and identification of ovarian cancer. Lancet 2002;360
   PubMedGoogle Scholar
• Elwood M. Proteomic patterns in serum and identification of ovarian cancer. Lancet 2002;360
   PubMedGoogle Scholar
• Pearl DC. Proteomic patterns in serum and identification of ovarian cancer. Lancet 2002;360
   PubMedGoogle Scholar
• Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 2004;20:777-85
   PubMed Web of Science ®Google Scholar
• Sorace JM, Zhan M. A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics 2003;4
   PubMedGoogle Scholar
• Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study. J Natl Cancer Inst 2007;99:838-46
   PubMed Web of Science ®Google Scholar
• Dalton WS, Friend SH. Cancer biomarkers–an invitation to the table. Science 2006;312:1165-8
   PubMed Web of Science ®Google Scholar
• Koomen JM, Haura EB, Bepler G, et al. Proteomic contributions to personalized cancer care. Mol Cell Proteomics 2008
   PubMedGoogle Scholar
• Hanash S, Pitteri S, Faca V. Mining the plasma proteome for cancer biomarkers. Nature 2008;452:571-9
   PubMed Web of Science ®Google Scholar
• Wingren C, Borrebaeck CAK. Antibody microarrays: Current status and key technological advances. OMICS 2006;10:411-27
   PubMed Web of Science ®Google Scholar
• Spisak S, Tulassay Z, Molnar B, Guttman A. Protein microchips in biomedicine and biomarker discovery. Electrophoresis 2007;28:4261-73
   PubMed Web of Science ®Google Scholar
• Ingvarsson J, Wingren C, Carlsson A, et al. Detection of pancreatic cancer using antibody microarray-based serum protein profiling. Proteomics 2008;8:2211-9
   PubMed Web of Science ®Google Scholar
• Carlsson A, Wingren C, Ingvarsson J, et al. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays. Eur J Cancer 2008;44:472-80
   PubMed Web of Science ®Google Scholar
• VanMeter AJ, Rodriguez AS, Bowman ED, et al. Laser Capture Microdissection and Protein Microarray Analysis of Human Non-small Cell Lung Cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type. Mol Cell Proteomics 2008;7:1902-24
   PubMed Web of Science ®Google Scholar
• Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003;3:253-66
   PubMed Web of Science ®Google Scholar
• Costello JF, Frühwald MC, Smiraglia DJ, et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000;24:132-8
   PubMed Web of Science ®Google Scholar
• Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003;3:253-66
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148-59
   PubMed Web of Science ®Google Scholar
• Kawakami K, Brabender J, Lord RV, et al. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 2000;92:1805-11
   PubMed Web of Science ®Google Scholar
• Alaminos M, Davalos V, Cheung NK, et al. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J Natl Cancer Inst 2004;96:1208-19
   PubMed Web of Science ®Google Scholar
• Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Ann Rev Pharmacol Toxicol 2005;45:629-56
   PubMed Web of Science ®Google Scholar
• Wei SH, Balch C, Paik HH, et al. Prognostic DNA methylation biomarkers in ovarian cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 2006;12:2788-94
   PubMed Web of Science ®Google Scholar
• Cho WCS. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007;6:60
   PubMed Web of Science ®Google Scholar
• Blenkiron C, Miska EA. MiRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet 2007;16:R106-R113
   PubMed Web of Science ®Google Scholar
• Calin G, Croce C. MicroRNA-Cancer Connection: The Beginning of a New Tale. Cancer Res 2006;66:7390-4
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska E, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8
   PubMed Web of Science ®Google Scholar
• Calin GA, Liu CG, Sevignani C, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004;101:11755-60
   PubMed Web of Science ®Google Scholar
• Calin GA, Trapasso F, Shimizu M, et al. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 2005;352:1667-76
   PubMed Web of Science ®Google Scholar
• Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65:7065-70
   PubMed Web of Science ®Google Scholar
• Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2005
   PubMedGoogle Scholar
• Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-98
   PubMed Web of Science ®Google Scholar
• Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008;299:425-36
   PubMed Web of Science ®Google Scholar
• Bentley D. Whole-genome re-sequencing. Curr Opin Genet Dev 2006;16:545-52
   PubMed Web of Science ®Google Scholar
• Shendure J, Porreca G, Reppas N, et al. Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome. Science 2005;309:1728-32
   PubMed Web of Science ®Google Scholar
• Harris T, Buzby P, Babcock H, et al. Single-Molecule DNA Sequencing of a Viral Genome. Science 2008;320:106-9
   PubMed Web of Science ®Google Scholar
• Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotech 2008;26:1135-45
   PubMed Web of Science ®Google Scholar
• Ledford H. The death of microarrays? Nature 2008;455:847
   PubMed Web of Science ®Google Scholar
• Shendure J. The beginning of the end for microarrays? Nat Meth 2008;5:585-7
   PubMed Web of Science ®Google Scholar
• Kahvejian A, Quackenbush J, Thompson J. What would you do if you could sequence everything? Nat Biotech 2008;26:1125-33
   PubMed Web of Science ®Google Scholar
• Shendure J. The beginning of the end for microarrays? Nat Meth 2008;5:585-7
   PubMed Web of Science ®Google Scholar
• Ledford H. The death of microarrays? Nature 2008;455:847
   PubMed Web of Science ®Google Scholar
• Gevaert O, Smet FD, Timmerman D, et al. Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks. Bioinformatics 2006;22
   PubMedGoogle Scholar
• Daemen A, Gevaert O, De Moor B. Integration of clinical and microarray data with kernel methods. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Conference 2007; 2007:5411-5
   Google Scholar
• Stephenson AJ, Smith A, Kattan MW, et al. Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy. Cancer 2005;104:290-8
   PubMed Web of Science ®Google Scholar
• Daemen A, Gevaert O, De Bie T, et al. Integrating microarray and proteomics data to predict the response on cetuximab in patients with rectal cancer. Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing. 2008;166-77
   Google Scholar
• Gevaert O, Van Vooren S, De Moor B. Integration of microarray and textual data improves the prognosis prediction of breast, lung and ovarian cancer patients. Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing. 2008;279-90
   Google Scholar
• Gevaert O, Van Vooren S, De Moor B. A Framework for Elucidating Regulatory Networks Based on Prior Information and Expression Data. Ann NY Acad Sci 2007;1115:240-8
   PubMed Web of Science ®Google Scholar
• Djebbari A, Quackenbush J. Seeded Bayesian Networks: constructing genetic networks from microarray data. BMC Syst Biol 2008;2
   PubMedGoogle Scholar
• Nevins JR, Huang ES, Dressman H, et al. Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum Mol Genet 2003;12 Spec No 2
   PubMedGoogle Scholar
• Pittman J, Huang E, Dressman H, et al. Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. PNAS 2004;101:8431-6
   PubMed Web of Science ®Google Scholar